Phibro Animal Health Receivables

Phibro Animal Health (PAHC) currently reports a receivables of $220M as of March 2026. That compares with $200M in the prior-year period — up 12.2% year over year. Use the charts on this page to explore Phibro Animal Health's receivables history and peer comparisons.

Phibro Animal Health's receivables increased from $200M to $220M — a 12.2% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Phibro Animal Health reported $220M in receivables as of March 2026. That compares with $200M in the prior-year period — up 12.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $220M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Phibro Animal Health, and consider following PAHC for alerts when major investors trade the stock.

Phibro Animal Health is classified in the Healthcare sector. On receivables, it currently shows $220M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PAHC with unrelated industries.